NCT04979780 2024-10-31
OSCAR-US
Bayer
Completed
Clinical Trials
11 trialsNCT05150938 2023-12-18
A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)
Bayer
Completed
NCT05112666 2023-04-03
A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)
Bayer
Completed
NCT02935530 2019-05-14
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Huazhong University of Science and Technology
Phase 3 Completed
NCT03282643 2019-04-16
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
Capital Medical University
Phase 1/2 Completed
NCT02073682 2019-03-06
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
Phase 3 Completed
NCT02746185 2018-08-13
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT00827554 2016-04-01
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT00577096 2015-04-06
Effects of Exercise in Combination With Epoetin Alfa
University of Arkansas
Phase NA Completed
NCT01945879 2013-09-19
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer
CONKO-Studiengruppe
Phase 1/2 Completed
NCT00771563 2013-06-28
SYRINGES
University Hospital, Antwerp
Phase 3 Completed